We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+2.16%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$34.7B
AUM Growth
+$242M
(+0.7%)
Cap. Flow
-$120M
Cap. Flow
% of AUM
-0.35%
Top 10 Holdings %
Top 10 Hldgs %
14.95%
Holding
3,089
New
65
Increased
2,336
Reduced
597
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$47.6M |
| 2 |
Medtronic
MDT
|
+$41.4M |
| 3 |
SLB Ltd
SLB
|
+$25M |
| 4 |
American Airlines Group
AAL
|
+$19.2M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$18.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$107M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$68.5M |
| 3 |
Apple
AAPL
|
+$22.9M |
| 4 |
CFN
CAREFUSION CORPORATION
CFN
|
+$16.9M |
| 5 |
PETM
PETSMART INC
PETM
|
+$14M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.74% |
| 2 | Financials | 14.67% |
| 3 | Healthcare | 14.62% |
| 4 | Industrials | 10.93% |
| 5 | Consumer Discretionary | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
Curtiss-Wright
CW
$28B
| $5.62M | 0.02% |
76,036
+3,595
| +5% | +$251K |
|
777
Arch Capital
ACGL
$33.9B
| $5.59M | 0.02% |
272,124
-1,470
| -0.5% | -$29.4K |
|
778
AGCO
AGCO
$7.51B
| $5.58M | 0.02% |
117,125
+7,760
| +7% | +$364K |
|
779
Fossil Group
FOSL
$360M
| $5.57M | 0.02% |
67,563
-264
| -0.4% | -$24.3K |
|
|
WNR
780
DELISTED
Western Refining Inc
WNR
| $5.57M | 0.02% |
112,686
+13,690
| +14% | +$572K |
|
781
Amdocs
DOX
$6.02B
| $5.55M | 0.02% |
102,100
+2,060
| +2% | +$104K |
|
|
POLY
782
DELISTED
Plantronics, Inc.
POLY
| $5.55M | 0.02% |
104,755
+32,196
| +44% | +$1.65M |
|
783
First Solar
FSLR
$26.2B
| $5.55M | 0.02% |
92,758
-3,820
| -4% | -$196K |
|
784
Rollins
ROL
$18.2B
| $5.54M | 0.02% |
503,951
-14,206
| -3% | -$143K |
|
785
SLM Corp
SLM
$5.24B
| $5.52M | 0.02% |
594,698
+41,608
| +8% | +$391K |
|
786
Royal Gold
RGLD
$17.5B
| $5.51M | 0.02% |
87,379
-13,685
| -14% | -$940K |
|
787
CNO Financial Group
CNO
$5.14B
| $5.51M | 0.02% |
320,112
+2,710
| +0.9% | +$44.7K |
|
|
SPLK
788
DELISTED
Splunk Inc
SPLK
| $5.49M | 0.02% |
92,789
+3,550
| +4% | +$215K |
|
789
Lazard
LAZ
$4.26B
| $5.48M | 0.02% |
104,258
+3,360
| +3% | +$166K |
|
790
The GEO Group
GEO
$4.18B
| $5.47M | 0.02% |
187,578
+2,550
| +1% | +$72.7K |
|
791
DexCom
DXCM
$32.8B
| $5.47M | 0.02% |
350,860
+46,340
| +15% | +$700K |
|
792
Jack in the Box
JACK
$329M
| $5.44M | 0.02% |
56,744
+4,945
| +10% | +$448K |
|
793
ITT
ITT
$18.3B
| $5.44M | 0.02% |
136,336
+10,550
| +8% | +$412K |
|
|
DNY
794
DELISTED
DONNELLEY R R & SONS CO
DNY
| $5.44M | 0.02% |
283,322
+25,030
| +10% | +$480K |
|
795
Compass Minerals
CMP
$1.25B
| $5.43M | 0.02% |
58,214
+4,100
| +8% | +$374K |
|
|
GXP
796
DELISTED
Great Plains Energy Incorporated
GXP
| $5.42M | 0.02% |
203,109
+15,285
| +8% | +$423K |
|
|
IM
797
DELISTED
Ingram Micro
IM
| $5.41M | 0.02% |
215,180
+16,820
| +8% | +$428K |
|
|
SGI
798
Somnigroup International
SGI
$14.7B
| $5.39M | 0.02% |
373,732
+31,000
| +9% | +$429K |
|
|
VVC
799
DELISTED
Vectren Corporation
VVC
| $5.39M | 0.02% |
122,150
+8,845
| +8% | +$405K |
|
800
Fair Isaac
FICO
$22.6B
| $5.38M | 0.02% |
60,682
+6,717
| +12% | +$540K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2015 Portfolio in Review
As of Q1 2015, RhumbLine Advisers held 3,089 positions worth $34.7B, up 0.7% from $34.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q1 2015: portfolio turnover was 3.9%. RhumbLine Advisers opened 65 new positions and exited 54, leaving the 3,089-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q1 2015 buy was Qorvo: 254,331 shares worth $20.3M.
- RhumbLine Advisers added most to Allergan plc in Q1 2015, an estimated $47.6M increase.
- RhumbLine Advisers's biggest Q1 2015 reduction was Apple, cutting an estimated $22.9M.
- RhumbLine Advisers fully exited Allergan Inc in Q1 2015, selling an estimated $107M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $34.7B portfolio in Q1 2015.
- RhumbLine Advisers opened 65 new positions and closed 54 in Q1 2015.
- RhumbLine Advisers's portfolio value rose 0.7% quarter-over-quarter to $34.7B.
Based on RhumbLine Advisers's 13F filing for Q1 2015, filed 12 May 2015.